Antidepressants account for only 10% of fall in suicide rates among older people

Apr 15, 2008

The use of antidepressants is likely to account for only 10 per cent of the fall in suicide rates among middle aged and older people, suggests a large study in the Journal of Epidemiology and Community Health. Globally, more than 800, 000 people commit suicide every year.

Rates have been falling in many countries, a factor that has been associated with better recognition of depression and the increasing use of antidepressants, particularly the newer selective serotonin reuptake inhibitors (SSRIs).

But research involving more than 2 million Danes aged 50 and above and living in Denmark between 1996 and 2000, throws this into question.

The researchers assessed changes in the numbers of middle aged and older people committing suicide during this period and the types of antidepressant drugs they had been prescribed.

Only one in five of those committing suicide was actually taking antidepressants at the time of death.

Suicide rates in older men fell by almost 10 per 100, 000 of the population during this timeframe, but among recipients of antidepressants, the fall was less than one.

For older women, only 0.4 of the 3.3 fall per 100, 000 of the population was accounted for by those being treated with antidepressants.

Overall, treatment type made little difference, although rates among men taking SSRIs were slightly higher than among those taking tricyclics.

Suicide rates were five to six times higher among those taking antidepressants than those who were not.

Previous Scandinavian and US research has suggested that a fivefold increase in the use of antidepressants could lead to a 25% decrease in suicide rates, with SSRIs having saved as many as upwards of 33, 000 lives, say the authors.

Sales of antidepressants in Denmark have soared from 8.4 per 1000 of the population in 1990 to 52.2 in 2000.

And suicide rates among older people have more than halved from 52.2 in 1980 to 22.1 per 100, 000 of the population in 2000.

The authors conclude that current antidepressant treatment accounts for only a fraction of the falls in suicide rates among older people.

But they nevertheless suggest that more should be done to pick up and treat depression among older people.

Source: British Medical Journal

Explore further: Protalix signs supply deal with Brazilian govt

add to favorites email to friend print save as pdf

Related Stories

Decrease in suicide not linked to newer antidepressants

Sep 29, 2010

Many researchers have studied the relationship between the increase in sales of new antidepressants in recent decades and a simultaneous decline in the suicide rate. In a study based on figures from the Nordic countries, ...

Tai chi beats back depression in the elderly, study shows

Mar 16, 2011

The numbers are, well, depressing: More than 2 million people age 65 and older suffer from depression, including 50 percent of those living in nursing homes. The suicide rate among white men over 85 is the highest in the ...

Few surgeons seek help for suicidal thoughts

Jan 17, 2011

As many as one in 16 surgeons reported having suicidal thoughts in the previous year, but few sought help from a mental health clinician, according to a report in the January issue of Archives of Surgery.

Awareness is key to fighting depression

Nov 06, 2010

A spate of suicides around the country by gay teens and young adults has directed the spotlight on depression. Dr. Meena Vimalananda, medical director of child and adolescent services at Sheppard Pratt Health System ...

Recommended for you

Protalix signs supply deal with Brazilian govt

8 hours ago

Shares of Protalix BioTherapeutics Inc. jumped in premarket trading Wednesday after the drug developer announced a deal that requires the Brazilian government to buy at least $280 million of the company's Gaucher disease ...

EU fines pharma firms over generics delay (Update)

8 hours ago

(AP)—The European Union has fined Danish pharmaceuticals multinational Lundbeck and several other producers a combined 146 million euros ($195 million) for delaying the market entry of cheaper generic alternatives ...

Investigational drug improves sleep disorder among the blind

Jun 17, 2013

An investigational new drug significantly improved a common and debilitating circadian rhythm sleep disorder that frequently affects people who are completely blind, a multicenter study finds. The results were presented Monday ...

User comments : 0

More news stories

US doctors' group labels obesity a disease

(HealthDay)—In an effort to focus greater attention on the weight-gain epidemic plaguing the United States, the American Medical Association has now classified obesity as a disease.

Sexually transmitted HPV declines in US teens

The number of US girls with the sexually transmitted disease HPV has dropped by about half even though relatively few youths are getting the vaccine, research showed on Wednesday.

Sound waves precisely position nanowires

(Phys.org) —The smaller components become, the more difficult it is to create patterns in an economical and reproducible way, according to an interdisciplinary team of Penn State researchers who, using ...

Multiview 3-D photography made simple

Computational photography is the use of clever light-gathering tricks and sophisticated algorithms to extract more information from the visual environment than traditional cameras can.